Sagility India IPO Day 2 Subscription Hits 0.33x as of 11:21 AM

Sagility India IPO, one of the upcoming IPOs in India, opened for subscription on November 5, 2024, and will close tomorrow on November 7, 2024. The share allotment is expected to be finalised on Friday, November 8, 2024. The IPO will be listed on both BSE and NSE and the tentative listing date is set for Tuesday, November 12, 2024.

Sagility India IPO is a book-built issue valued at ₹2,106.60 crore, consisting of only an offer for sale of 70.22 crore shares.

Sagility India IPO price band is set between ₹28 and ₹30 per share. Retail investors must apply for a minimum lot size of 500 shares. The minimum investment required for a retail investor is ₹15,000. Additionally, the issue reserves up to 19,00,000 shares for employees at a discount of ₹2 per share from the issue price.

The objectives of the offers are to achieve the benefits of listing the equity shares on the stock exchanges and to carry out the offer for sale of up to 702,199,262 equity shares of the face value of ₹10 each by the promoter selling shareholder.

As of November 6, 2024, at 09:31 AM, the Sagility India IPO GMP is ₹0.

Sagility India IPO Subscription Status

• On Day 1, November 5, 2024, Sagility India IPO was subscribed 0.23 times overall. The retail category was subscribed 1.14 times, QIB at 0.00 times, and NII at 0.08 times, while the employee category stands at 1.43 times. 
• On Day 2, November 6, 2024, as of 11:21 AM, Sagility India IPO was subscribed 0.33 times. The retail category was subscribed 1.59 times, QIB at 0.00 times, and NII at 0.11 times, while the employee category stands at 1.93 times. 

About Sagility India Limited

The company offers technology-enabled business solutions and services customised to the US healthcare industry. As a pure-play provider focused on healthcare services, Sagility’s client base includes payers which are the US health insurance companies that finance and reimburse health service costs and providers primarily hospitals, physicians, and companies in diagnostics and medical devices.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.